Skip to main content
Log in

Analysis of multiple primary cancers in patients with urologic cancer

  • Original Articles
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The study of the clinical features of multiple primary cancers (MPC) may provide insight into the pathogenesis of specific cancers, as well as the issue of treatment-related induction of second tumors.

Methods

Between 1972 and 1995, 94 of 765 patients with urologic cancer treated at our hospital had MPC. We retrospectively analyzed the clinical features of these patients, and compared them with those of the 671 patients with single primary cancers (SPC).

Results

The frequency of MPC among all 765 patients was 12.3%. The average age at diagnosis of urologic cancer in the male patients was significantly higher in the MPC group than in the SPC group. In the MPC group, the organs most commonly involved were the bladder and prostate (urologic cancers), and the stomach and lung (nonurologic cancers). Adenocarcinoma was the most common tumor in the MPC group. The interval between the first and second cancer diagnoses was significantly longer in female patients with MPC than in male patients. No significant difference between the MPC and SPC groups was observed in the distribution of ABO blood groups or in the frequency of history of tobacco or alcohol use. Four MPC patients had second cancers considered to have been induced by the treatment for the first cancer. The prognoses were significantly poorer for the patients with MPC. The rate of death due to urologic cancer was much lower in the patients with MPC than in those with SPC.

Conclusions

We found that more than 10% of the 765 patients with urologic cancer whose cases we reviewed had another primary cancer. Because the number of cases of MPC is increasing, it is important to be aware of the possibility of the development of MPC and to therefore carefully follow up cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Matzkin H, Braf Z. Multiple primary malignant neoplasms in the genitourinary tract: occurrence and etiology. J Urol 1989;142:1–12.

    PubMed  CAS  Google Scholar 

  2. Dieckmann KP, Wegner HEH, Krain J. Multiple primary neoplasms in patients with testicular germ cell tumor. Oncology 1994;51:450–458.

    Article  PubMed  CAS  Google Scholar 

  3. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932;16:1358–1414.

    Google Scholar 

  4. Wegner HEH. Multiple primary cancers in urologic patients: audit of 19-year experience in Berlin and review of the literature. Urology 1992;39:231–236.

    Article  PubMed  CAS  Google Scholar 

  5. Boffetta P, Kaldor JM. Secondary malignancies following cancer chemotherapy. Acta Oncol 1994;33:591–598.

    PubMed  CAS  Google Scholar 

  6. Kakizaki H, Abe Y, Sugano O, Kato H. A hundred cases of multiple primary neoplasms in association with genitourinary cancer. Jpn J Urol 1992;83:1841–1846 (in Japanese).

    CAS  Google Scholar 

  7. Takahashi S, Sugimoto M, Shinohara M, Kinoshita K. Clinical analysis of multiple primary cancers associated with bladder cancer. Jpn J Urol 1992;83:1118–1123 (in Japanese).

    CAS  Google Scholar 

  8. Kakizoe T, Matsumoto K, Nishino Y, Ohtani M. Double cancer observed from bladder cancer. Jpn J Clin Urol 1983;37:805–809 (in Japanese).

    Google Scholar 

  9. Fujimoto I, Hanai A, Oshima A, Hiyama T, Tsukuma H, Murakami R, Sobue T, Tanaka H, Ajiki W. Incidence and mortality statistics. In: Fujimoto I, Hanai A, Hiyama T, Tsukuma H, Takasugi Y, Sugaya T (eds) Cancer incidence and mortality in Osaka 1963–1989. Tokyo: Shinohara Publishing, 1993:49–214.

    Google Scholar 

  10. Bokemeyer BC, Schmoll HJ. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 1995;13:283–292.

    PubMed  CAS  Google Scholar 

  11. Bokemeyer BC, Schmoll HJ. Secondary neoplasms following treatment of malignant germ cell tumor. J Clin Oncol 1993;11:1703–1709.

    PubMed  CAS  Google Scholar 

  12. Doll R, Peto R. The cause of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1192–1308.

    Google Scholar 

  13. Wynder EL, Gori GB. Contribution of the environment to cancer incidence: an epidemiologic exercise. J Natl Cancer Inst 1977;58:825–832.

    PubMed  CAS  Google Scholar 

  14. Day GL, Shore RE, Blot WJ, McLaughlin JK, Austin DF, Greeenberg RS, Liff JM, Preston-Martin S, Sarkar S, Schoenberg JB, Fraumeni JF. Dietary factors and second primary cancers: a follow-up of oral and pharyngeal cancer patients. Nutr Cancer 1994;21:223–232.

    Article  PubMed  CAS  Google Scholar 

  15. Gallo O, Bianchi S. p53 expression: a potential biomarker for risk of multiple primary malignancies in the upper aerodigestive tract. Oral Oncol Eur J Cancer 1995;31:53–57.

    Article  Google Scholar 

  16. Spits MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, Bondy ML, Hong WK, Hsu TC. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 1994;86:1681–1684.

    Google Scholar 

  17. Shah S, Evans DGR, Blair V, Burnell LD, Birch JM. Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry. Cancer 1993;72:819–827.

    Article  PubMed  CAS  Google Scholar 

  18. Horii A, Han HJ, Shimada M, Yanagisawa A, Kato Y, Ohta H, Yasui W, Tahara E, Nakamura Y. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res 1994;54:3373–3375.

    PubMed  CAS  Google Scholar 

  19. Shimada M, Horii A, Sasaki S, Yanagisawa A, Kato Y, Yamashita K, Okagawa K, Yamasaki K, Ishiguro S, Inoue M, Shiozaki H, Nakamura Y. Infrequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers of the esophagus and various other tissues. Jpn J Cancer Res 1995;86:511–515.

    PubMed  CAS  Google Scholar 

  20. Hoffman M, Roberts WS, Cavanagh D. Second pelvic malignancies following radiation therapy for cervical cancer. Obstet Gynecol Surv 1985;40:611–617.

    PubMed  CAS  Google Scholar 

  21. Pettersson F, Fotiou S, Einhorn N, Silfversward C. Cohort study of the long-term effect of irradiation for carcinoma of the uterine cervix. Acta Radiol Oncol 1985;24:145–151.

    PubMed  CAS  Google Scholar 

  22. Kleinerman RA, Curtis RE, Boice JD Jr, Flannery JT, Fraumeni JF Jr. Second cancers following radiotherapy for cervical cancer. J Natl Cancer Inst 1982;69:1027–1033.

    PubMed  CAS  Google Scholar 

  23. Duncan RE, Bennett DW, Evans AT, Aron BS, Schellhas HF. Radiation-induced bladder tumors. J Urol 1977;118: 43–45.

    PubMed  CAS  Google Scholar 

  24. Rosner F. Acute leukemia as a delayed consequence of cancer chemotherapy. Cancer 1976;37:1033–1036.

    Article  PubMed  CAS  Google Scholar 

  25. Harris CC. The carcinogenicity of anticancer drugs: a hazard in man. Cancer 1976;37:1014–1023.

    Article  PubMed  CAS  Google Scholar 

  26. Chabner BA. Second neoplasm—a complication of cancer chemotherapy. N Engl J Med 1977;297:213–215.

    Article  PubMed  CAS  Google Scholar 

  27. Kantor AF, McLaughlin JK. Second cancer following cancer of the urinary system in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985;68:149–159.

    PubMed  CAS  Google Scholar 

  28. Jensen OM, Knudsen JB, Sorensen BL. Second cancer following cancer of the urinary system in Denmark, 1943–80. Natl Cancer Inst Monogr 1985;68:349–360.

    PubMed  CAS  Google Scholar 

  29. Wegner HEH, Meier T, Klan R, Dieckmann KP. Bladder cancer following prostate cancer—an analysis of risk factors. Int Urol Nephrol 1994;26:43–51.

    PubMed  CAS  Google Scholar 

  30. Liscow AS, Neugut AI, Benson M, Olsson CA, Birkhoff J, Chang AC. Multiple primary neoplasms in association with prostate cancer in black and white patients. Cancer 1987;59:380–384.

    Article  Google Scholar 

  31. Greenberg RS, Rustin ED, Clard WS. Risk of genitourinary malignancies after cancer of the prostate. Cancer 1988;61: 396–401.

    Article  PubMed  CAS  Google Scholar 

  32. Kleinerman RA, Liebermann JV, Li FP. Second cancer following cancer of the male genital system in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985;68:139–147.

    PubMed  CAS  Google Scholar 

  33. Osterlind A, Rorth M, Prener A. Second cancer following cancer of the male genital system in Denmark, 1943–80. Natl Cancer Inst Monogr 1985;68:341–347.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Nakata, S., Kato, Y., Sato, J. et al. Analysis of multiple primary cancers in patients with urologic cancer. Int J Clin Oncol 2, 40–46 (1997). https://doi.org/10.1007/BF02492596

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02492596

Key words

Navigation